title: Neurotrophic paths in the treatment of depression.
authors: Shawn
authors: S
authors: Hayley
authors: Hymie
authors: H
authors: Anisman
mesh_terms: D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics / Q000378:metabolism / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D004921:Erythropoietin / Q000627:therapeutic use; D006801:Humans; D009414:Nerve Growth Factors / Q000235:genetics / Q000378:metabolism / Q000627:therapeutic use*; D009473:Neuronal Plasticity / Q000187:drug effects
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D004921:Erythropoietin
references: Mol Psychiatry. 2007 Dec;12(12):1079-88
references: 17700574
references: Eur Neuropsychopharmacol. 2010 Aug;20(8):535-44
references: 20167454
references: Brain Res. 2008 Mar 14;1199:148-58
references: 18267317
references: Dialogues Clin Neurosci. 2009;11(3):239-55
references: 19877493
references: Brain Res Brain Res Rev. 2000 Sep;33(2-3):199-227
references: 11011066
references: Psychopharmacology (Berl). 2011 Mar;214(1):319-28
references: 20703451
references: J Affect Disord. 2012 Feb;136(3):767-74
references: 22044630
references: Horm Behav. 2011 Mar;59(3):315-20
references: 20483357
references: Eur Neuropsychopharmacol. 2013 Aug;23(8):902-9
references: 23058261
references: Curr Opin Pharmacol. 2008 Feb;8(1):14-9
references: 18061540
references: J Affect Disord. 2013 Sep 25;150(3):707-19
references: 23769610
references: Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13208-13
references: 16924103
references: Cell Death Differ. 2008 Apr;15(4):783-92
references: 18259195
references: J Neurosci. 2006 Jan 4;26(1):126-37
references: 16399679
references: Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):573-94
references: 21619868
references: Neuropsychopharmacology. 2010 Nov;35(12):2378-91
references: 20686454
references: Cell Mol Life Sci. 2013 Jan;70(1):39-53
references: 22585060
references: Neuropharmacology. 2011 Feb-Mar;60(2-3):354-64
references: 20932982
references: Phys Med Biol. 2012 Apr 7;57(7):N65-81
references: 22407323
references: Science. 2003 Jul 18;301(5631):386-9
references: 12869766
references: Transl Neurosci. 2013 Mar 1;4(1):46-58
references: 23691270
references: Mol Psychiatry. 2009 Aug;14(8):746-54
references: 19455150
references: Psychopharmacology (Berl). 2012 Feb;219(3):687-98
references: 21947319
references: Drugs Today (Barc). 2012 Jul;48(7):469-78
references: 22844658
references: Science. 2012 Oct 5;338(6103):68-72
references: 23042884
references: Brain Res Bull. 2006 Jul 31;70(3):221-7
references: 16861106
references: Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9848-53
references: 19497871
references: Biol Psychiatry. 2009 Aug 1;66(3):267-74
references: 19185286
references: Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):264-70
references: 21996278
references: Eur J Pharmacol. 2004 Nov 28;505(1-3):93-101
references: 15556141
references: PLoS One. 2013 Jun 18;8(6):e65547
references: 23824678
references: Neurobiol Dis. 2013 Sep;57:28-37
references: 22691453
references: Curr Med Chem. 2011;18(28):4359-67
references: 21861813
references: Mol Psychiatry. 2011 Mar;16(3):252-64
references: 20661246